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Abstract. This paper presents a simulation study of BrachyShade, a proposed
internal source-tracking system for real time quality assurance in high dose rate
prostate brachytherapy. BrachyShade consists of a set of spherical tungsten
occluders located above a pixellated silicon photodetector. The source location is
estimated by minimising the mean squared error between a parametric model of
the shadow image and acquired images of the shadows projected on the detector
plane. A novel algorithm is finally employed to correct the systemic error resulting
from Compton scattering in the medium. The worst-case error obtained with
BrachyShade for a 13.5 ms image acquisition is less than 1.3 mm in the most
distant part of the treatment volume, while for 75% of source locations an error
of less than 0.42 mm was achieved.
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1. Introduction
Prostate cancer is the second most commonly diagnosed cancer (after non-melanoma
skin cancer) and one of the leading causes of cancer death among males in Australia
and worldwide (Gambarini et al., 2014). In 2017, it is estimated that there will be
16,665 new cases of prostate cancer and 3,452 deaths in Australia; in the United States,
the respective figures are 161,360 and 26,730 (AIHW National Mortality Database,
2017; Siegel et al., 2015; The American Cancer Society, 2017; Cancer Research UK,
2017).
High dose rate (HDR) brachytherapy is a popular form of radiotherapy commonly
used for treating prostate cancer. In HDR prostate brachytherapy (HDR PBT),
a small sealed capsule containing a high-activity radioactive source (typically 192Ir
or 60Co) is temporarily placed inside or adjacent to the target area. A robotic
afterloader automatically steps the radioactive source through a planned sequence
of positions in an array of catheters pre-implanted in the target area by the treating
physician, progressively delivering the specified radiation dose distribution throughout
the target volume. The accuracy of source placement is critical to the success of HDR
brachytherapy treatment, where the objective is to conformally deliver the prescribed
radiation dose to the target volume while limiting the incidental dose delivered to
surrounding radiation-sensitive healthy organs and tissues.
Deviations between the planned source positions and the actual positions achieved
during treatment can occur due to anatomical changes (e.g. due to intra-treatment
swelling or involuntary bowel or bladder movement), afterloader error or imperfect
catheter placement Kirisits et al., 2014. These deviations will result in a discrepency
between the planned and actual dose delivered to the target volume, potentially
harming healthy tissue or under-irradiating diseased tissue. Therefore, a reliable,
accurate, real-time 3D source tracking capability would be valuable for treatment
quality assurance; it could also potentially adjust a treatment plan in real-time if
positioning discrepancies are detected.
Several previous systems have been developed for source tracking during HDR
prostate brachytherapy, as detailed in Section 2; of these, one of the most promising
source tracking scheme currently available with true real-time 3D source tracking
capabilities is HDR BrachyView, developed by the University of Wollongong’s Centre
for Medical Radiation Physics. This device is essentially an in-body pinhole camera
with an integrated trans-rectal ultrasound (TRUS) probe. The camera combines a
multi-double-cone pinhole tungsten collimator with a high-resolution pixelated silicon
photodetector array, and the projected images of the source are analysed to estimate
the source position. While this device effectively solves the problem of real-time source
tracking for HDR prostate brachytherapy, the collimator is challenging to manufacture,
and the device must be rotated in situ in order to cover the entire volume.
This paper proposes a source tracking system, HDR BrachyShade, which is
inspired by HDR BrachyView, but takes a very different approach to source tracking.
The key idea is to use shadows of spherical tungsten occluders rather than projections
through pinholes in a tungsten collimator as the means of determining the source
position. This approach offers several advantages over the original design. Firstly,
high-precision spherical tungsten or tungsten alloy ball bearings are a low-cost
commodity item already in widespread industrial use, and the remainder of the
probe may be fabricated from any medical-grade polymer - or even 3D printed -
with great precision. This avoids the problem of accurately machining off-centre
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holes in a hard tungsten cylinder, which is necessary in HDR BrachyView due to
the unavoidable asymmetry of the detector’s printed circuit board (PCB). Secondly, a
higher photon flux reaches the detector surface compared to the original BrachyView
design; therefore, high-quality images may be acquired at a higher frame rate. Thirdly,
unlike a double-cone pinhole in a cylindrical-shell collimator, a spherical occluder is
entirely orientation-agnostic; it presents the same view to the source regardless of
its relative orientation. This makes the derivation of a good analytic approximation
of the relation between source position, occluder location and detected image quite
straightforward. Using this analytic model, the source position may be estimated
using an iterative error-minimisation algorithm, together with an empirical model
of the effects of Compton scattering within the medium. Finally, the orientation-
agnosticism of the spherical occluders mean that additional occluders may be placed
on either side of the central axis. This greatly expands the field of view of the detector,
allowing the entire prostate volume to be monitored without the need to mechanically
rotate the probe. Simulation studies have confirmed the properties of the proposed
design and source tracking methodology; the probe’s accuracy compares favourably
to the results previously published for HDR BrachyView. The probe is designed to be
able to determine the source location with an accuracy of better than 0.5 mm for any
point within a 40 × 40 × 40 mm cubic volume, with its centre located 40 mm above
the centre of the detector; this is equivalent to the volume which can be imaged by
HDR BrachyView.
Section 2 presents a summary of current techniques and devices used for source
tracking or dosimetry validation in HDR brachytherapy. Section 3 describes the design
of the probe, and the position estimation and Compton scatter correction algorithms,
and describes the simulations conducted to evaluate the accuracy of the source tracking
method. Section 4 presents the results of this simulation study, including an evaluation
of the efficacy of the Compton scatter correction method. Section 5 discusses the
implications of the results and compares the results to experimental results published
for HDR BrachyView. Finally, Section 6 concludes the paper and discusses the next
steps in the development of this design, including the first planned prototype and
plans for preclinical evaluation.
2. Related Work
Several dosimetric and imaging systems have been proposed to obtain an estimate of
the delivered dose distribution or to verify the source position during HDR prostate
brachytherapy. Although thermoluminescent dosimeters (TLDs) have been used
extensively to verify the absorbed dose at a given location of interest, these passive
dosimetry systems are incapable of providing measurements in real-time (Figueroa
et al., 2008; Batic et al., 2011; Lambert et al., 2007). An alternative approach is to
use an external solid-state semiconductor radiation detector system to monitor the
source position for quality assurance (QA) in HDR PBT. Since the dose rate from
an isotropic radiation source is inversely proportional to the square of the distance to
the detector, this may result in either a significant uncertainty in the estimation of
the source location or an acquisition time exceeding that needed for real time source
tracking (Han, 2015; Lambert et al., 2007).
More accurate measurements can be made if a compact radiation sensing system
is placed internally in the patient in close proximity to the treatment volume. Several
different methods have been proposed for in-body real-time HDR brachytherapy QA
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using various detector or dosimetry systems, including MOSFETs, diodes and plastic
scintillation detectors. While these systems can provide a good estimate of the
delivered dose and/or source position, most are either incapable of providing real-time
tracking information, are difficult to place comfortably inside the body, or are unable
to provide a sufficiently accurate estimate of source position (although they may offer
accurate dosimetry capabilities) (Reniers et al., 2012). For example, Lambert et al.
(2007) reported that although diamond detectors have been shown to offer adequate
sensitivity for HDR-PT QA with good radiation resistance, they are impractically
bulky, rendering them unsuitable for in-body applications. The diamond detector
also exhibited significant dose rate dependence and non-linearity at higher dose rates
(Therriault-Proulx et al., 2011).
Real-time dosimetry systems based on diode detectors have been used for dose
verification in HDR brachytherapy treatment. Although these systems can provide
rapid processing time and robust accuracy, their sensitivity is highly dependent on
distance to the source (Gambarini et al., 2014; Qi et al., 2012; Therriault-Proulx et al.,
2011). Seymour et al. (2011) investigated the use of a dosimeter consisting of an array
of five PTW diodes for estimating the dose delivered by a HDR-PBT source inside
the rectum. Dose values for 28 patients were acquired, and the deviations between
the device measurement and planned dose in 71% of the measured points were ±10%.
However, the error increased to ±20% when the fraction of points measured increased
from 71.1% to 95%. The results have shown that this system is only suitable for
select patients as the system is not always capable of being applied for subsequent
fractions; it is also only able to provide measurements for gross error in the delivered
dose rather than determining the distribution of that error. A further shortcoming of
this approach is that the diodes’ sensitivity decreases as the angle between the source
and the diode array increases, which can significantly degrade the accuracy of the
results.
Multi-point MOSFET detectors have been investigated for real-time dose
measurements during HDR PBT. These devices are very compact, offer good spatial
resolution and can provide immediate dose readout, making them a promising
candidate for QA in HDR-PBT (Gambarini et al., 2012; Gambarini et al., 2014;
Lambert et al., 2007; Qi et al., 2012). However, the law and variation in sensitivity
of the recorded dose, the non-water equivalence of the detector and the angular
dependence of MOSFET detectors limit the use of this system for accurate in-
body brachytherapy dosimetry (Lambert et al., 2007; Therriault-Proulx et al., 2011;
Wootton et al., 2014). A study using micro-MOSFETs for in-body dosimetry
was performed by Qi et al. (2012) to evaluate the dose received by a patient
undergoing HDR intracavitary brachytherapy of nasopharyngeal carcinoma (NPC).
They investigated the use of an array of five MOSFETs which were calibrated
independently in a water phantom, resulting in dose calibration factor of 0.46 ± 0.012
Gy/mV for the 192Ir source. Dose values for 11 NPC patients were obtained with a
good agreement with the predicted dose measurements of -0.3 ± 3.9% (right side) and
-0.3 ± 3.7% (left side).
A recent dosimetric study conducted by Gambarini et al. (2014) used
MOSkin detectors to perform real-time in-vivo dose measurements during prostate
brachytherapy. They conducted their experiments inside a urethral catheter in a gel
phantom (emulating a real prostate) and using an 192Ir radioactive source with an
active length of 3.6 mm. Single and dual-MOSkin detectors were calibrated in a water
phantom at a distance of 38 mm from the source. The maximum discrepancy between
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the planned and measured dose was 8.9% and 3.8% for single and dual MOSkin
detectors respectively.
Plastic scintillation detectors (PSDs) have been proposed as a mechanism for
real-time verification of HDR brachytherapy treatment. Plastic scintillation detectors
are compact and water-equivalent, while providing good dose linearity, independence
to dose rate, fast response, temperature independence and energy independence above
100 KeV, and as such are an attractive candidate for in-body dosimetry and imaging
(Cartwright et al., 2010; Therriault-Proulx et al., 2013; Wootton et al., 2014).
A clinical study conducted with an in-body plastic scintilltor detector system was
performed by Therriault-Proulx et al. (2011) to determine the feasibility of using
PSDs for QA during 192Ir HDR prostate brachytherapy treatment. The proposed
system consists of a green plastic scintillator fibre, 1 mm in diameter and 3 mm long,
coupled to a light-shielded 1 mm × 7 mm optical fibre. A total of 13 parallel catheters
were inserted in a water phantom (35 cm × 35 cm × 25 cm), and the ratio of the
measured dose in 43 specific dwell positions with dwell time of 5 s compared to the dose
predicted by the treatment planing system (TPS). The dosimetry system recorded a
delivered dose of 99.6 ± 3.2% to 100.5 ± 1.5% and 104.3 ± 0.3% of the planned dose
in the urethra and the rectal wall, respectively.
A second design based on PSDs, known as BrachyFOD, was described by
Cartwright et al. (2010), in which an insertable applicator was developed for in-body
use which provides real-time dose mapping and source tracking of an HDR prostate
brachytherapy source. In this study, the deviation between the planned and measured
dose was found to range from 2% to 3%, and the average error between the predicted
and the calculated source position was approximately 2 mm. However, the authors
noted that the error in estimating the source position can be up to 9 mm when the
distance between the source and the scintillator is more than 100 mm.
Duan et al. (2001) investigated the use of a pinhole-based imaging system for in-
body monitoring and verification of 192Ir HDR brachytherapy. The developed system
consists of a pinhole collimator combined with an X-ray fluoroscope and a radiographic
film-screen. This system can recognise source images for dwell times ranging from 2
to 400 s with an error between the planned and reconstructed dwell positions varying
from 0.3 to 0.8 mm. However, the authors discussed the limitations of their technique
and indicated that their method is not applicable in clinical cases of short dwell times
due to the limited dynamic range of the screen-film combinations. It is also not able
to provide real-time source tracking capabilities as the film image cannot be accessed
until after the procedure.
Smith et al. (2013) developed a source-tracking and dosimetry system which
estimates the 3D position of an HDR brachytherapy source by fitting a Lorentz
(Cauchy) function to intensity profiles of the 2D radiation distribution projected onto
a large external electronic portal imaging device (EPID) - a copper build-up layer
and scintillating screen coupled to an array of amorphous silicon photodiodes. The
uncertainty in position estimation is dominated by the z-component, which is up to
2 mm for the greatest source-detector distance. To achieve this accuracy, an acquisition
time of 10 seconds was required. The long acquisition time required to achieve this
sensitivity is due to the large source-detector distance necessary for this type of source
tracking system; much of the available information in the image is also discarded, since
only profiles through the point of maximum intensity are fitted.
The verification of catheter position in HDR prostate brachytherapy via
electromagnetic tracking has been proposed by several authors, including Poulin et al.
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(2015) and Beaulieu et al. (2018), as an alternative to CT verification of catheter
position post-implantation/pre-irradiation. The EM tracking system evaluated by
Beaulieu et al. (2018) was shown to outperform clinical CT, with a worst-case error of
1.25 mm for tip tracking and 1.91 mm for the overall catheter position for acquisitions
of 10 seconds per catheter. However, to date most research with such electromagnetic
tracking systems has concentrated on verifying catheter positition prior to irradiation
rather than tracking the source itself; post-implantation tissue swelling, involuntary
patient movement and other factors may introduce further deviations from the planned
source position by the start of the first or subsequent fractions.
2.1. HDR BrachyView
One of the most promising innovations for HDR PBT QA is the BrachyView family
of devices, developed at the University of Wollongong’s Centre for Medical Radiation
Physics, with two separate variants proposed for HDR and LDR PBT by Safavi-Naeini
et al. (2013) and Petasecca et al. (2013) and Alnaghy et al. (2017), respectively. HDR
BrachyView performs real-time monitoring of the position of the 192Ir source during
HDR prostate brachytherapy treatment. The probe consists of a semi-cylindrical
tungsten pinhole collimator, suspended 6.5 mm over a 4×1 array of Timepix pixellated
silicon detectors. Source tracking is performed by locating the centres of mass of
each projection of the source on the imaging plane, back-projecting lines through
the pinholes, and identifying the point of maximum convergence. The probe’s
performance has been evaluated both via Monte Carlo simulation and experiment,
with the maximum overall error between the planned and measured source position
being 1 mm for the majority of evaluated source positions located in the target volume
(a 40 mm × 40 mm × 40 mm volume above the detector). However, the error in
estimated source position increases when the distance between the detector and the
source is larger, reaching a maximum of 1.3 mm for a source which lies in the extreme
corners of the treatment volume. Sensitivity also varies depending on the arrival angle
of the photons at the pinholes, restricting its field of view (FoV) to the acceptance
angle of the double-cone pinholes; therefore, to monitor the entire potential treatment
volume, it may be necessary to mechanically rotate the probe in situ, depending on
whether the source will move beyond the detector FoV for a single angular orientation
of the probe. Finally, due to the fact that most incident photons are blocked by the
collimator, overall detector sensitivity is limited by the size of the pinholes (as there
is an intrinsic trade-off between sensitivity and pinhole camera resolution (Alnaghy
et al., 2016). The minimum acquisition time needed to obtain images of sufficient
quality for sub-millimetre tracking accuracy is around 300 ms.
In summary, one of the most promising systems for real-time HDR prostate
brachytherapy QA is HDR BrachyView; however, there remains an opportunity for
further improvement in ease of manufacturing, acquisition speed and FoV coverage.
3. Materials and Methods
3.1. Probe Design
The probe consists of a linear 4×1 array of silicon Timepix detectors, positioned in
the centre of a cylindrical plastic shell with an outer diameter of 24 mm. The shell
has a thickness of 4 mm, with a 1.5 mm groove cut in both inner surfaces, to support
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Figure 2. Clinical context of BrachyShade.
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the printed circuit board (PCB) on which the Timepix detectors are mounted. Three
spheres of MT-18F tungsten alloy (95% W, 3.5% Ni, 1.5% Fe), 4 mm in diameter, are
embedded in the plastic shell, with their centres located 10 mm above the centre of the
detector plane, directly above the midpoints of the joints between adjacent Timepix
detectors. The FoV of the detector is defined as the wedge-shaped volume above the
detector in which the source will project a partial shadow onto the detector plane. A
3D rendering of the proposed design is shown in Figure1; the use of the probe, showing
its location relative to the prostate, is shown in Figure 2.
The geometry of the probe, including the number and location of occluders, has
been chosen to maximise the FoV. The occluders may be positioned closer to the
detector to increase the FoV; however, this is at the cost of reduced spatial resolution
in the estimated source position. The field of view limitation does not seriously impede
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the function of the imaging system; for cases where the FoV is insufficient to capture
all movements of the source, the probe may be sheathed in a thin plastic shell which
remains fixed while allowing the probe to rotate; alternatively, additional occluder
configurations (for example, two pairs of occluders placed on either side of the central
axis of the probe at a 45◦ angular offset from the vertical) can be used to increase the
FoV.
Each Timepix detector itself consists of a square silicon slab, 300 µm thick and
14 mm across, divided into a 256×256 array of square pixels with a pitch of 55 µm.
Readout from an array of Timepix detectors can be performed using an interface such
as FITpix, which enables data acquisition via a USB2.0 port on a host PC. A FITpix
interface coupled to a single Timepix detector can theoretically read out up to 90
frames per second, with a dead time of 11 ms between frames during which no charge
can be collected; in practice, acquisition times of 100 ms or more are typically used.
The Timepix detector can operate in several different modes: it can collect per-pixel
particle/photon counts, per-pixel spectroscopic data or per-pixel time of arrival data.
For this project, the Timepix is operated in count mode.
Coregistration of the probe (and hence the estimated source position) with the
prostate is achieved via TRUS. The external rigid plastic shell remains in place, the
BrachyShade probe is withdrawn and a modified TRUS probe is inserted, acoustically
coupled to the external shell via ultrasound gel. This procedure may be repeated
several times during the procedure to monitor the position of the prostate relative to
the coordinate system of the probe, to account for peristaltic and other involuntary
patient motion. This is similar to the procedures used with BrachyView probes, as
described in Alnaghy et al. (2017).
3.2. Source Position Estimation Algorithm
The source position estimation algorithm is based on an analytic model of the expected
pattern of photons which interact with the detector plane, given the source and
occluder positions, which is described in detail in Section 3.3. From a starting point
somewhere in the volume above the occluders, the analytic model is used to generate
the expected detected photon distribution on the detector. The mean squared error
between the detected photon map and the image acquired by the Timepix array is then
iteratively minimised by adjusting the estimated source position using the Levenberg-
Marquardt algorithm, until the algorithm converges or an arbitrary maximum number
of iterations is reached. Convergence is normally achieved in less than 30 iterations;
the hard limit is set to 100.
In reality, however, the analytic model is imperfect; specifically it does not account
for the effects of Compton scatter in the medium. However, the effects of Compton
scatter on the estimated source position are quite deterministic, and can be corrected
using a simple empirically-derived error model, described in detail in Section 3.4.
3.3. Analytic Model
The model uses a right-handed coordinate system with its origin located at the physical
centre of the sensitive volume of the detector array, as shown in Figure 3. The source is
assumed to be an 192Ir point source located at position Ps = (xs, ys, zs); the occluders
are placed at Ok = (0, yo,k, zo) mm, k ∈ [1, 2, 3]. Photons emitted from this source
are subject to a number of possible sources of attenuation and Compton scattering.
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Figure 3. Analytic model, showing all key geometric parameters. The source is
located at Ps = (2.5, 5.0, 20) mm.
Firstly, the photon path intersects with a volume of water (or approximately water-
equivalent tissue). Secondly, it may traverse a maximum of one tungsten-alloy sphere
(it is possible for the photon path to intersect with more than one sphere only if
the source is located outside of the prostate volume). Finally, any detectable photon
will pass through the plastic shell (which is approximately tissue-equivalent) and a
small volume of air in the void above the detector, before reaching the detector plane.
Photons arriving at the detector may or may not be detected, with the probability
of detection dependent on the energy of the photon and the angle of arrival. The
Timepix is operated in count mode, with a conservative energy threshold of 16 keV.
To estimate the distribution of photons which would be detected for a given source
location, a map of the gamma photon intensity which would arrive at the detector in
the absence of media between the source and the detector is generated. At a distance
d from a source emitting N photons of a particular wavelength per unit time, the flux





At a point Pd = (xd, yd, 0) on the detector plane, d =
√
(xd − xs)2 + (yd − ys)2 + z2s .
Furthermore, the angle between the normal of an infinitesimal area dA centred at





(xd − xs)2 + (yd − ys)2 + z2s
)
; therefore, the flux density at the surface,
based on free-space path loss only, will be:
φfs(xd, yd) =
N
4π((xd − xs)2 + (yd − ys)2 + z2s)
× zs√
(xd − xs)2 + (yd − ys)2 + z2s
=
Nzs
4π((xd − xs)2 + (yd − ys)2 + z2s)
3
2
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The path length through water can be calculated by finding the distance from
the source to the point of intersection between the line from Pd to Ps and the inner
surface of the cylinder. The cylinder itself is assumed to be water-equivalent. We
assume that water only attenuates incident gamma photons and do not attempt to
model Compton scattering. This assumption is not valid in practice; however, analytic
modelling of Compton scatter is difficult and computationally expensive, since in order
to determine the effect of scatter on the shadows, the angle of arrival would need to
be computed for each photon, negating the value of an analytic model. Instead, we
ignore scattering at this stage and apply an empirical correction factor at a later stage
of the process of determining source location.









where t is the distance along this line from Pd, lx = (xs−xd)/d, ly = (ys− yd)/d,
lz = zs/d and d =
√
(xs − xd)2 + (ys − yd)2 + z2s . Solving for the point of intersection
between this line and the inner surface of the cylinder (with radius Rc) reduces to
finding the point of intersection between the upper half of a circle of radius Rc and
the projection of the previously-mentioned line on the xz plane, since the cylinder is
parallel to the y axis:
R2c = (xd + tlx)
2 + (tlz)
2











This parameter can be substituted back into (1) to solve for the coordinates of the
point of intersection, which allows the distance through water by a photon emitted by
the source arriving at the detector plane to be calculated, and hence the probability
that this photon will be absorbed or transmitted through that space:
px = xd + tlx




(px − xs)2 + (py − ys)2 + (pz − zs)2 (2)
For each of the k tungsten-alloy occluders, (1) can be solved simultaneously with
the equation of a sphere of radius Ro centred at Ok. This results in a quadratic
equation, with the discriminant:
∆ = ((xs − xd)xd + (ys − yd)(yd − ys)− zszo)2
− (x2d + (yd − ys)2 + z2o) +R2o (3)
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If this discriminant is positive, the line from the detector plane to the source






∆ ∆ > 0
0 ∆ ≤ 0
The path length through the occluder, if any, is also subtracted from the path
length through water. The number of photons of wavelength λi per unit time per unit
area arriving at the surface of the detector are then:
φarr(xd, yd) = φfs(xd, yd)e
−µH2O(λi)(dH2O−dW )e−µW (λi)dW
where µH2O(λi) and µW (λi) are the linear attenuation coefficients of water and
tungsten alloy at wavelength λi, respectively. The number of photons which deposit
some energy during their interaction with the detector (either photoelectrically or,
more frequently, through Compton scattering) per unit time per unit area depends on
the thickness of silicon through which they pass, which in turn depends on the angle
of arrival - a simple function of the relative position of the source and the point on
the detector and the thickness of the detector, tdet. To simplify the analytic model,
we ignore the fact that the path from the source to a given pixel on the detector may
intersect with more than one pixel, and assign the totality of interaction probability
to the pixel centred at (xd, yd):







To generate a good approximation of the expected map of detected photons for a
given source position (xS , ys, zs), the area of the detector is quantised into individual
pixels (in the case of the Timepix detector, these pixels are each 55 µm × 55 µm
in size), φdet is calculated at the centre of each pixel for each wavelength present
in the source spectrum, multiplied by the area of the pixel and the duration of
the observation; the total count is summed by weights corresponding to the relative
distribution of wavelengths in the source spectrum.
3.4. Compton Scatter Correction
While the analytic model described in Section 3.3 provides a good estimate of the
shadow map in the absence of a scattering medium, the probe is intended for use inside
the human body, where Compton scattering is significant. Compton scattering reduces
the contrast between the illuminated and shadowed regions, since some photons can ‘go
around’ the occluders. The discrepancy between the physical process and the analytic
model has a relatively small impact on the accuracy of the estimate of the position
in the x and y dimensions; however, it results in a significant overestimate (of the
order of 10%) of the source position in z. Analytic modelling of the three-dimensional
distribution of photon paths from a point source in a Compton-scattering medium is
complex; most published models for Compton scatter only attempt to estimate spectra
or dose distribution on a plane for a point source in a uniform medium (i.e., without
the presence of occluding objects).
Instead, in this work, an empirical model is used to model and correct the effects
of Compton scatter on the estimated source position. Defining the volume of interest
as a 40 mm × 40 mm × 40 mm cube centred at (0, 0, 40) mm, it may be observed that
both the BrachyShade probe itself and the volume of interest (VoI) are symmetric
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about both the xz and yz planes. Therefore, a model developed for correcting the
error in the positive xy quadrant of the VoI, (0 ≤ x ≤ 20, 0 ≤ y ≤ 20, 20 ≤ z ≤ 50),
can be applied to the other quadrants by symmetry. A 9 × 9 × 9 equally-spaced
lattice of locations is constructed within this volume, with points spaced by 2.5 mm
in x and y and 5 mm in z, for a total of 729 point within the quarter-FoV. A set
of Geant4 (version 10.3p2) simulations were conducted with a simulated 192Ir point
source placed at each of these locations. A total of 5 billion primaries were simulated;
the acquired images were then used together with the fitting algorithm to estimate the
source location for each point, and the error vector between the ground truth location
and the estimated source positions calculated.
Two distinct classes of error vectors are observed. The first, and most useful in
this work, is the set of error vectors at points for which most or all of the shadows are
projected onto the detector surface, corresponding to a wedge-shaped region parallel
to the y axis. In this region, denoted R1, the error vectors point approximately
towards the origin of the coordinate system, and have a magnitude of the order 10%
of the distance from the origin. The magnitude and direction of this error vector vary
smoothly as a function of position, implying that a relatively simple mathematical
model describing the error as a function of position can be derived. The boundary of
this region can easily be determined by a simple examination of the geometry of the
probe - it is an inverted triangular prism with an acceptance angle of 55.3◦. A second
class of points in the quarter-FoV is also observable - this is the set of points which
do not project a shadow on the detector plane; these still encode some information
in the detected-photon distribution, but with much less specificity, as there is little
structure in the image which can be used to accurately discern source location. This
region is denoted R2. Finally, there is also a small intermediate region, Ri for which
the shadow is partially on the detector plane.
Of these regions, the R1 is of the greatest interest, since it offers the lowest
error; it also corresponds to the bulk of the nominal prostate volume. Ri is also
of interest, since some structure still exists in the projected image. For simplicity,
the remainder of this paper assumes that the region of interest includes R1 and the
part of Ri where at least half of the shadow is visible on the imaging plane. This
region is an inverted triangular prism with an acceptance angle of 73.7circ, and its
axis of translation parallel to the long axis of the probe. Like HDR BrachyView, if
the FoV is insufficient to observe the entire treatment volume, it is possible to rotate
the imaging system around its y axis relative to its (stationary) outer shell to achieve
the desired coverage. Unlike HDR BrachyView, it is also possible to add additional
lateral occluders to ensure that an orientable shadow pattern is observed even where
the three primary occluders do not cast a shadow on the detector surface.
In the primary FoV region, the smoothly varying error vector field can be
approximated well as a polynomial function of estimated source position. The error
correction model has been implemented with a linear, second-order (quadratic) and
third-order model; the quadratic model was found to result in a smaller residual error
compared to the linear model, and the third-order model performs no better than the
quadratic. Therefore, for the remainder of this work, a second-order quadratic model
for the error field is adopted.
While it is possible to express this error field as a function of true source position,
which makes more intuitive sense, expressing it as a function of estimated source
position allows the error to be conveniently corrected. The problem, then, becomes
one of determining the coefficients ax|y|z,{1−7} which, given the estimated position
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(x̂, ŷ, ẑ), allow the error to be determined and hence corrected:
ex = ax,1x̂
2 + ax,2x̂+ ax,3ŷ
2 + ax,4ŷ + ax,5ẑ
2 + ax,6ẑ + ax,7
ey = ay,1x̂
2 + ay,2x̂+ ay,3ŷ
2 + ay,4ŷ + ay,5ẑ
2 + ay,6ẑ + ay,7
ez = az,1x̂
2 + az,2x̂+ az,3ŷ
2 + az,4ŷ + az,5ẑ
2 + az,6ẑ + az,7 (4)
The coefficients ax|y|z,{1−7} may be calculated by constructing an system of linear
equations from the estimated source positions and calculated errors within R1, and
determining the least-squares fit. An exact solution cannot be obtained, since each
observation of the error is noisy (due to the statistical noise inherent in the simulation);
however, the large number of points available allow a good estimate of the coefficients
to be obtained.
Given a set of N non-collinear points inside the first region (with the condition









where ex|y|z(k) is the error component in x, y or z for the kth point in the first
region, k ∈ [1, 2, . . . , N ]. Now, defining
P =

x̂(1)2 x̂(1) ŷ(1)2 ŷ(1) ẑ(1)2 ẑ(1) 1
x̂(2)2 x̂(2) ŷ(2)2 ŷ(2) ẑ(2)2 ẑ(2) 1
x̂(3)2 x̂(3) ŷ(3)2 ŷ(3) ẑ(3)2 ẑ(3) 1
. . .


















Since P is not square (the number of rows exceeds number of columns), the Moore-
Penrose pseudoinverse P+ is used, calculated via singular value decomposition (SVD).
The resulting coefficients Ax|y|z, for the x, y and z components, respectively, represent
the optimal least-squares solution to the (overdetermined) problem. These coefficients
can be used, together with the estimated source location returned by the position-
estimation algorithm, to provide an estimate of the error in the source location, which
can simply be added to the estimated source location to provide an improved estimate
(x̂′, ŷ′, ẑ′) for any point inside R1.
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Figure 4. Simulation model in Geant4. The source is located at Ps =
(2.5, 5.0, 20) mm (as for Figure 3).
3.6 mm




0.6 mm Ir core
192
Figure 5. The simulated 192Ir HDR brachytherapy source. The core consists
of pure iridium with a uniform distribution of 192Ir, surrounded by a steel shell
(Borg et al., 1999a; Han et al., 2014).
3.5. Monte Carlo Simulations
Simulations were performed using Geant4 10.3p2. Electromagnetic interactions were
modelled using the Livermore Low Energy physics package, with cuts of 1 µm in the
target region and 4 mm in the phantom region, for all gamma, electron and positron
interactions. For scatter correction, each of the 729 source positions was simulated
with 5 billion decays. For a typical source air kerma Sk = 4.11 × 104 µGy m2h−1
(corresponding to an activity of 370 GBq), this corresponds to an acquisition period
of 13.5 ms. True radioactive decay is not modelled; instead, photons are emitted
from a uniformly distributed random location within the source model, in a uniformly
distributed random direction, with the proportions of each photon energy determined
according to the 192Ir spectrum (see Table 1). This provides a realistic model for the
spectrum of the real source, regardless of the age of the source, since 192Ir decays
directly into stable 192Pt, with no other radioactive species produced. In the real
source, all β− radiation is blocked by the steel shell (see Figure 5).
The source model used for this work is the 192Ir MicroSelectron-HDR, described
by Borg et al. (1999a), Borg et al. (1999b) and Daskalov et al. (1998). The core
consists of a pure iridium metal cylinder, 3.6 mm long and 0.6 mm in diameter, with
192Ir uniformly distributed throughout the volume. This is surrounded by a steel shell,
4.5 mm long and 0.9 mm in diameter, which is connected to a short steel cable (2 mm
long and 0.7 mm in diameter). A schematic of the source is shown in Figure 5.
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Table 1. 192Ir gamma spectrum (Borg et al., 1999a)






















Figure 6 shows an example of simulation output and corresponding results from the
fitting process. A significant and systemic error is evident; each component of the
source position is overestimated, with the biggest error being in the z dimension.
Upon comparison of Figures 6(a) and 6(b), it may be seen that the contrast between
the shadow region and the directly illuminated part of the detector is much less in
the simulation compared to the analytic model, because the analytic model does not
account for Compton scattering. This results in some radiation being scattered around
the occluder, illuminating parts of the detector which would be in shadow if it were
not for the scattered photons. The total illumination of the detector is therefore less
than the analytic model would predict for the same source position, resulting in an
overall bias towards a more distant estimated source position.
4.2. Compton Scatter Correction
Figure 7(a) shows the error at each of points in one quarter of the FoV as a vector field
(error vectors are shown at the same scale as the spatial dimensions in the figure). The
fitted second-error polynomial model of the error field is shown in Figure 7, evaluated
at all points in this volume. Note that the model is evaluated at all 729 points in the
rectangular 20 mm × 20 mm ×40 mm volume; however the model is not valid outside
of the field of view.
After subtracting the estimated error from the uncorrected source position
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Figure 6. Example of raw output from Geant4 simulations (37×109 primary
particles, real 192Ir source model centred at (18.75, 20, 60) mm), with the results
of the fitting process and the difference between the two. Without Compton
scatter correction, the fitting algorithm estimates the location as being (22.0,
21.9, 70.8) mm.
estimates, the residual error field is as shown in Figure 7(c).
Figure 8 shows the magnitude of the error as a function of distance from the
origin, before and after Compton scatter correction. Post-correction, the error only
increases slightly with increasing distance over the range of the treatment volume.
Error statistics for Compton-corrected position estimates of both point source
and realistic source model simulations are shown in Table 2.
5. Discussion
For both the point source and real source model, the median error is less than 0.3 mm.
In both cases, the maximum error is less than 1.5 mm (1.3 mm for the realistic source
model) - however, this is an outlier (and is essentially due to the limited SNR of
the 13.5 ms acquisitions of the most distant source locations). At the vast majority
(more than 75%) of locations in the quarter-FoV, the post-correction error is less than





































































(c) Corrected Error Field
Figure 7. Error vector field as a function of estimated source position; fitted
second-order polynomial model of the error vector field; residual error after
correction added to original position estimate.
20 25 30 35 40 45 50 55 60 65



























Figure 8. Error as a function of distance from (0, 0, 0), before and after applying
the Compton scatter correction field.
Table 2. Magnitude of the residual error after Compton scatter correction; with
an accurate model of an HDR brachytherapy source, the residual error is less than
1.137 mm for all evaluated source positions and less than 0.4141 mm in 75% of
positions.
Point source (mm) Real source model (mm)
Minimum 0.02256 0.0223
1st quartile 0.1550 0.1831
Median 0.2291 0.2818
3rd quartile 0.3755 0.4141
Maximum 1.426 1.2941
BrachyShade: Shadow-Based Internal Source Tracking for HDR PBT 18
0.5 mm. The median error is largely determined by the SNR of the image, and will
be further reduced with longer acquisitions with better SNR. The probe is intended
to operate with an acquisition period of 100 ms or more, which should improve the
SNR by a factor of more than 2.5. The direction of the residual error field observed in
Figure 7(c) is essentially random; it is no longer biased and it gradually increases with
distance from centre of the detector plane (i.e. the origin of the coordinate system).
Based on the Monte Carlo simulation results presented in the preceding section,
it is clear that Compton scatter correction is absolutely essential for the proper
estimation of source position. The proposed correcting Compton scatter is very
effective, with the residual error in the position estimate now determined principally
by the SNR which can be achieved during a given acquisition interval. With the
current simulation results, and with a realistic model of the radioactive source, an
error of less than 1.3 mm is achievable even for acquisitions with a much lower SNR
than is achievable in practice, while the majority of locations exhibit an error less
than 0.5 mm. The accuracy of location estimation is comparable to that offered by
HDR BrachyView (a maximum value of 1.3 mm), however it can be achieved with a
significantly shorter acquisition time (in this instance, 13.5 ms compared to a minimum
of 300 ms for HDR BrachyView for an equivalent level of accuracy) and with simpler
and cheaper manufacturing.
For the 3-occluder HDR BrachyShade probe, the field of view is limited by the
volume above the detector for which a shadow is at least partially projected onto the
imaging plane. The addition of further occluders to the left and right of the three
occluders modelled in this paper is straightforward, and ensures that a shadow will
be projected onto the imaging plane even for much more extreme source positions,
essentially extending the field of view to the entire 40 mm × 40 mm × 40 mm volume
above the probe. This requires no substantial modifications of either the source
position estimation algorithm or the Compton scatter correction algorithm; it does
somewhat increase the execution time for evaluation of the analytic model.
The accuracy of fitting depends on both the signal to noise (SNR) of the acquired
image (which in turn depends on the acquisition time and the proximity of the source)
and also the pixel dimensions. Increasing pixel dimensions both increases the SNR (as
each pixel will detect a larger number of photons) and decreases the spatial resolution
with which the photon distribution can be measured. The pixel pitch of Timepix
is 55 µ m, which is much higher than needed for this application; therefore, it is
possible to improve the SNR without degrading overall accuracy by rebinning pixels
into larger groups. This has the added benefit of significantly increasing the speed
of the fitting process, since it greatly reduces the number of calculations needed for
error minimisation. For a realistic exposure interval of 100 ms, with a typical HDR
brachytherapy source air kerma strength of Sk = 4.11×104 µGy m2h−1 (corresponding
to a source activity of 370 GBq), rebinning in both x and y by a factor of either 4 or 8
resulted in the best overall performance (approximately the same in both cases). This
provides a 16-fold or 64-fold reduction in the number of pixels in the image, greatly
accelerating the fitting process.
A multithreaded C-based implementation of the fitting algorithm converges
within approximately 250-300 ms on a fast PC (quad-core 7th-generation Intel i7),
allowing a 100 ms acquisition and position estimate to be completed in under
0.5 seconds; however, acquisition of the next frame may begin immediately after the
transfer of the previous frame, so with more processing power and further optimisation
of the algorithm, the position could be estimated every 111 ms (or less, if slightly less
BrachyShade: Shadow-Based Internal Source Tracking for HDR PBT 19
precision is acceptable). This this should be feasible on recent (2018) high-end Intel
and AMD CPUs.
6. Conclusion
A source tracking system was developed which uses shadows cast by tungsten occluders
to identify the position of a HDR brachytherapy source in real time. Source tracking
with an accuracy of better than 1.3 mm was obtained for a 13.5 ms image acquisition
period (for a typical HDR brachytherapy source) at all source locations within the FoV,
with the estimated source position being within 0.5 mm in the majority of locations.
The Compton scatter correction algorithm was able to largely correct errors in the
estimated source position which result from scattering in the medium.
The next steps planned in the development of HDR BrachyShade over the next
twelve months include a detailed simulation evaluation of a 7-occluder variant with
increased FoV, performance evaluation with a 60Co source, performance evaluation
with simulated 100 ms acquisitions for a range of points within the treatment volume,
and fabrication of a prototype (currently in development) for evaluating real-world
performance with an actual brachytherapy source. An alternative position-based
localisation algorithm based on a high-speed template-matching algorithm is also in
development, and will be compared to the method proposed in this paper.
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